U
Power Law company profile
UniQure
Biotech & Life Sciences · Amsterdam, Netherlands · Founded 1998 · IPO 2014 Unicorn
Valuation
$496M
Market cap · Apr/2026
Revenue
$16M
Latest reported FY
Global footprint
Where UniQure has talent and traffic
AI talent share
1.3%
of workforce is AI talent
(4 of 313 staff)
(4 of 313 staff)
Core AI10.32%
Other AI30.96%
Non-AI workforce30998.72%
Web traffic by country
36K
monthly visits
across markets
across markets
🇺🇸 United States32.8%
🇨🇦 Canada11.7%
🇳🇱 Netherlands9.7%
🏳️ Korea8.3%
🏳️ Republic of6.9%
Patent intelligence
$58M patent portfolio · 22 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$58M
11.6% of market cap · 13.5× smaller than top peer BioNTech ($780M)
22 active patent families
Where UniQure innovates
Molecular biologyCell biologyParvovirusNucleotide sequencingRibosomal RNA Genes
Above peer median on Market
Quality vs same-sector peers
UniQure on the five Patsnap quality dimensions
UniQure in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where UniQure concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across UniQure and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee UniQure on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.